
I-SIS News # 3
The following warnings come from a letter from N. Tomlinson of UK
MAFF's Joint Food Safety and Standards Group dated 4 December
1998 to the US FDA, commenting on its draft document, "Guidance for
Industry: Use of Antibiotic Resistance Marker Genes in Transgenic
Plants".
The letter from MAFF cites new findings from the University of Leeds
showing "the relative difficulty with which plant DNA is degraded
during processing"(p.4). It mentions other new research showing that
bacteria in the mouth can take up foreign DNA and express the
gene(s); and transformable bacteria are also present in the
respiratory tract.
MAFF warns that "there is a case to be concerned about the problem
of gene transfer to environmental organisms" and that bacteria that
have taken up the antibiotic resistance genes "could also act as a
gene pool that may interact with human pathogens." (p.4).
"The widespread use of transgenics carrying antibiotic resistance
marker genes will involve a massive amplification of these genes in
the biosphere. Whether or not these genes are expressed,
amplification on the scale that will occur when transgenic crops are
planted in large fields means that arguments about the rarity of
possible transfer events will become less significant." (p.5).
MAFF cites recent publications showing that transgenic DNA may gain
access into mammalian cells by being carried in pathogenic bacteria
that invade cells. The ampicillin-resistance marker gene encodes a
beta-lactamase which inactivates penicillin and other penicillin-like
antibiotics. This gene is highly mutable, and hence capable of
extending its spectrum of resistence to many other similar
antibiotics. "Human respiratory flora contains notable potential
pathogens including Neisseria meningitidis and Streptococcus
pneumoniae. These bacteria do not currently exhibit high-level,
beta-lactamase mediated resistance to penicillins." (p.5)
Dr. Mae-Wan Ho , a scientists who has been warning of these
possibilities of horizontal gene transfer to unrelated species for
several years, says,"It is irresponsible for the Government to continue
with the massive farm-scale field trials in view of the evidence its
own scientists are taking into account." She points out that
transgenic pollen can travel for miles. Not only farm workers and food
processors, but the general public will also be exposed to transgenic
DNA, while bees will certainly take it up and contaminate the honey.
There is no provision to monitor for horizontal gene transfer or
impacts on health in the current farm-scale trials.
The current farm-scale field trials involve herbicide-tolerant
transgenic maize and canola. The transgenic maize carries a
'disrupted' ampicilllin-resistance gene, which is not expressed.
However, given the mutability of that gene, it may become
re-activated in bacteria.
** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. **
|
|
|
Last Updated on 4/19/00 By Rachel C. Benbrook Email: karen@biotech-info.net |
|